FTC seeks new approach for reviewing pharmaceutical mergers
The Federal Trade Commission has launched a working group of international enforcers looking for new ways to analyse and challenge pharmaceutical mergers.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10